GLP-1 Agonist for Weight Loss

Weight Loss, type 2 diabetes

Hosted on MSN · 3d

Weight Loss Revolution Part 1: The pros and cons of weight loss drugs

Obesity is an epidemic in the United States, but more people are shedding pounds with the help of weight loss drugs.

FOX News on MSN · 21h

Weight-loss, diabetes drugs linked to vision problems in small study

GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

News Medical · 5d

What's Next for Semaglutide? Beyond Diabetes and Weight Loss

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research into its broader health impacts.

The Hill on MSN · 3d

Study finds rare vision issues in taking GLP-1 weight loss drugs

Researchers looked at the nine people who had vision problems while using the drugs and is one of several that have documented vision problems while people are taking GLP-1 medica

AOL · 12h

Is Ozempic safe for weight loss? What doctors want you to know about blockbuster drug

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 drugs, and whether they're safe.

Straight Arrow News on MSN · 1d

Vision loss possibly linked to Ozempic, weight loss injections: Study

Millions of Americans use GLP-1 injections like Ozempic to lose weight. A study is questioning whether they can cause vision loss.

healthday20h

Many With Overweight, Obesity Discontinue GLP-1 Receptor Agonists Within One Year

Many patients with overweight or obesity discontinue glucagon-like peptide-1 (GLP-1) receptor agonist therapy within o ...

Neurology Advisor11d

GLP-1 Receptor Agonists Tied to Risks and Benefits Beyond Weight Loss

HealthDay News — For people with diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduced risk for certain disorders and conditions, including ...

3don MSN

Weight loss drug semaglutide may reduce alcohol cravings, heavy drinking and smoking, new study finds

Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...

News Medical on MSN11d

High discontinuation rates of GLP-1 agonists found among patients with obesity

Discontinuation of GLP-1 receptor agonists in obesity is common, driven by weight regain and socioeconomic factors, impacting ...

HeraldNet9d

GLP-1 Weight Loss Medications Made Easy – How Clinic Secret Works

However, Clinic Secret has emerged as a potential game-changer in weight loss by offering a clinically proven, accessible solution that leverages the power of GLP-1 medications. In this ...

Medscape2d

Paying For GLP-1s: If Medicare Starts, Will Other Insurers Follow Suit?

If the CMS rule to cover obesity medications is finalized, coverage will increase by other insurers, experts predicted. HHS ...

WDRB4d

The 2 sides of Ozempic — weight loss success stories and health nightmares in Kentucky

The popular weight-loss drugs known as GLP-1 receptor agonists, which were originally meant to treat diabetes, surged in ...

1don MSN

Yes, GLP-1 Medications Really Do Reduce Alcohol Cravings, Per A New Study

It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...

Psychology Today3d

An Unexpected Irony of Popular Weight-Loss Therapy

A study finds GLP-1 weight-loss drugs may pose vision risks, revealing an unexpected medical irony. A paradoxical insight: ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results